Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs

A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment

NCT00004581 ·Status: COMPLETED ·Phase: PHASE3

A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors

NCT00004580 ·Status: COMPLETED ·Phase: PHASE1

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

NCT00028366 ·Status: COMPLETED ·Phase: NA

Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects

NCT00358917 ·Status: COMPLETED ·Phase: PHASE3

ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects

NCT00004578 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Once-Daily Drug Regimen for HIV-Infected Patients

NCT00001968 ·Status: COMPLETED ·Phase: PHASE1

A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors

NCT00038636 ·Status: COMPLETED ·Phase: PHASE3

Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults

NCT00118898 ·Status: COMPLETED ·Phase: PHASE3

A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen

NCT00931463 ·Status: COMPLETED ·Phase: PHASE4

The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir

NCT00000898 ·Status: COMPLETED ·Phase: NA

Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients

NCT00752037 ·Status: COMPLETED ·Phase: PHASE4

Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults

NCT00389207 ·Status: COMPLETED ·Phase: PHASE3

A Study of 1592U89 in HIV-Infected Patients

NCT00002388 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1

NCT00823979 ·Status: TERMINATED ·Phase: PHASE2

A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARC

NCT00002046 ·Status: COMPLETED ·Phase: NA

Atazanavir/Ritonavir Maintenance Therapy

NCT00084019 ·Status: COMPLETED ·Phase: NA

Tenofovir-lamivudine-dolutegravir Combination as Second-line ART: a Randomised Controlled Trial

NCT03991013 ·Status: COMPLETED ·Phase: PHASE2

Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment

NCT00006591 ·Status: UNKNOWN ·Phase: NA

TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients

NCT00896051 ·Status: COMPLETED ·Phase: PHASE2

Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients

NCT00038220 ·Status: COMPLETED ·Phase: PHASE2

Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)

NCT00552240 ·Status: COMPLETED ·Phase: PHASE4

Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)

NCT00028301 ·Status: COMPLETED ·Phase: PHASE3

GW873140 In Combination With Kaletra In HIV Infected Subjects

NCT00102778 ·Status: TERMINATED ·Phase: PHASE2

Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects

NCT00043966 ·Status: COMPLETED ·Phase: PHASE3

HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults

NCT00450580 ·Status: COMPLETED ·Phase: PHASE3